We recommend against adopting administration proposals to reduce provider rates for certain services and charge copayments to Medi-Cal beneficiaries. We propose a different copayment approach. We recommend approval of a proposal to reduce the cost of Medi-Cal drug purchases and offer some additional approaches that could save the state money on purchases of drugs.